Parametric Portfolio Associates’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Parametric Portfolio Associates’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,342	Closed	-$44K	–	3982
2020 Q2	$44K	Buy	+4,342	New	+$39.9K	﹤0.01%	3874
2020 Q1	–	Sell	-4,160	Closed	-$36K	–	4030
2019 Q4	$36K	Buy	+4,160	New	+$23.3K	﹤0.01%	3939
2019 Q3	–	Sell	-3,696	Closed	-$61K	–	4012
2019 Q2	$61K	Buy	3,696 +319	+9%	+$5.54K	﹤0.01%	3898
2019 Q1	$56K	Buy	+3,377	New	+$48.6K	﹤0.01%	3882
2018 Q4	–	Sell	-3,601	Closed	-$144K	–	3973
2018 Q3	$144K	Buy	+3,601	New	+$102K	﹤0.01%	3813
2016 Q2	–	Sell	-17,275	Closed	-$372K	–	3956
2016 Q1	$372K	Buy	+17,275	New	+$366K	﹤0.01%	3491

Other funds holding MRNS

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Parametric Portfolio Associates's MRNS Position: Q3 2020 in Review

Parametric Portfolio Associates sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2020, closing a stake of 4,342 shares — an estimated $44K sold.

Parametric Portfolio Associates first reported a position in MRNS in Q1 2016 and held it in 6 quarters. The position peaked at $372K in Q1 2016. 77 funds tracked by Wall St. Rank hold MRNS as of Q3 2020.

Parametric Portfolio Associates reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
Parametric Portfolio Associates sold 4,342 Marinus Pharmaceuticals, Inc shares in Q3 2020, an estimated $44K.
Parametric Portfolio Associates first reported a position in Marinus Pharmaceuticals, Inc in Q1 2016 and held it in 6 quarters.
Parametric Portfolio Associates's Marinus Pharmaceuticals, Inc position peaked at $372K in Q1 2016.
77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2020.

Based on Parametric Portfolio Associates's 13F filing for Q3 2020, filed 12 Nov 2020.